Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Apr:73:22-7.
doi: 10.1016/j.ypmed.2014.12.019. Epub 2015 Jan 5.

Efficacy of a tobacco quitline among adult cancer survivors

Robert C Klesges  1 , Rebecca A Krukowski  2 , James L Klosky  3 , Wei Liu  4 , Deo Kumar Srivastava  4 , James M Boyett  4 , Jennifer Q Lanctot  5 , Melissa M Hudson  6 , Charla Folsom  5 , Harry Lando  7 , Leslie L Robison  5
Affiliations
Randomized Controlled Trial

Efficacy of a tobacco quitline among adult cancer survivors

Robert C Klesges et al. Prev Med. 2015 Apr.

Abstract

Objective: The purpose of the study (conducted 2010-2013) was to determine the efficacy of two common types of tobacco quitlines in adult cancer survivors who regularly smoked cigarettes.

Method: Adult onset cancer survivors in Memphis, Tennessee (n=427, 67% female, 60% Caucasian) were randomized either to a Proactive (i.e., counselor-initiated calls) or Reactive (i.e., participant-initiated calls) quitline. Both conditions also received nicotine replacement therapy. The primary outcome was biochemically-verified (i.e., salivary cotinine) smoking cessation.

Results: While 12-month self-reported abstinence was consistent with other published studies of smoking cessation (22% and 26% point prevalence abstinence for Proactive and Reactive conditions, respectively), 48% of participants who were tested for cotinine failed biochemical verification, indicating a considerable falsification of self-reported cessation. Adjusted cessation rates were less than 5% in both intervention conditions.

Conclusion: Our results are consistent with other studies indicating that traditional smoking cessation interventions are ineffective among cancer survivors. Moreover, self-reports of cessation were unreliable in cancer survivors participating in a quitline intervention, indicating that future studies should include biochemical verification. Given the importance of smoking cessation among cancer survivors and low cessation rates in the current study, it may be necessary to design alternative interventions for this population. ClinicalTrials.gov identifier: NCT00827866.

Keywords: Adults; Cancer; Intervention studies; Smoking cessation; Survivors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Quitline study consort diagram.
See this image and copyright information in PMC

References

    1. Asfar T, et al. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict. Behav. 2011;36(7):764–768. - PMC - PubMed
    1. Benowitz NL, et al. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002;4(2) - PubMed
    1. Benowitz NL, et al. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am. J. Epidemiol. 2009;169(2):236–248. - PubMed
    1. Browman GP, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N. Engl. J. Med. 1993;328(3):159–163. - PubMed
    1. Cooke F, et al. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob. Res. 2008;10(4):607–612. - PubMed

Publication types

Associated data